Active substance
Results for the substance linagliptin metformin
2 results
About this active substance
The combination of linagliptin and metformin is used to treat type 2 diabetes. Linagliptin is a DPP-4 inhibitor that increases insulin secretion, while metformin reduces glucose production in the liver and improves insulin sensitivity.
This combination is taken orally, usually twice daily, and is used alongside a healthy diet and regular exercise to control blood sugar levels. It is recommended for patients who cannot control their blood sugar with metformin alone.
Side effects may include nausea, diarrhea, headaches, or upper respiratory tract infections. In rare cases, lactic acidosis (a serious complication) or pancreatitis may occur.
Patients should inform their doctor about any other medications they are taking and strictly follow the administration instructions. Pregnant or breastfeeding women should consult a specialist before using this combination.
This combination is taken orally, usually twice daily, and is used alongside a healthy diet and regular exercise to control blood sugar levels. It is recommended for patients who cannot control their blood sugar with metformin alone.
Side effects may include nausea, diarrhea, headaches, or upper respiratory tract infections. In rare cases, lactic acidosis (a serious complication) or pancreatitis may occur.
Patients should inform their doctor about any other medications they are taking and strictly follow the administration instructions. Pregnant or breastfeeding women should consult a specialist before using this combination.